DOI QR코드

DOI QR Code

Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) could accelerate burn wound healing in hamster skin

  • Received : 2011.03.30
  • Accepted : 2011.09.01
  • Published : 2012.06.30

Abstract

Burns are one of the most devastating forms of trauma and wound healing is a complex and multicellular process, which is executed and regulated by signaling networks involving numerous growth factors, cytokines, and chemokines. Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) was specifically produced from rice cell culture through use of a recombinant technique in our laboratory. The effect of rhGM-CSF on promotion of deep second-degree burn wound healing on the back skin of a hamster model was evaluated through a randomized and double-blind trial. As macroscopic results, hamster skins of the experimental groups showed earlier recovery by new epidermis than the control groups. Immunohistochemical reactions of proliferating cell nuclear antigen and transforming growth factor-b1, which are indicators of cell proliferation, were more active in the experimental group, compared with the control group. On electron microscopy, basal cells in the epidermis of the experimental group showed oval nuclei, prominent nucleoli, numerous mitochondria and abundant free ribosomes. In addition, fibroblasts contained well-developed rough endoplasmic reticulum with dilated cisternae. Bundles of collagen fibrils filled the extracellular spaces. Particularly, ultrastructural features indicating active metabolism for regeneration of injured skin at 15 days after burn injury, including abundant euchromatin, plentiful free ribosomes, and numerous mitochondria, were observed. These findings suggest that use of rhGM-CSF could result in accelerated deep second-degree burn wound healing in animal models.

Keywords

References

  1. Arellano M, Lonial S. 2008. Clinical uses of GM-CSF, a critical appraisal and update. Biologics. 2:13-27.
  2. Barreda DR, Hanington PC, Belosevic M. 2004. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol. 28:509-554. https://doi.org/10.1016/j.dci.2003.09.010
  3. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic- Canic M. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen. 16:585-601. https://doi.org/10.1111/j.1524-475X.2008.00410.x
  4. Braunstein S, Kaplan G, Gottlieb AB, Schwartz M, Walsh G, Abalos RM, Fajardo TT, Guido LS, Krueger JG. 1994. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol. 103:601-604. https://doi.org/10.1111/1523-1747.ep12396936
  5. Cianfaran F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T. 2006. Granulocyte/ macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol. 154:34-41. https://doi.org/10.1111/j.1365-2133.2005.06925.x
  6. Dorsett-Martin WA. 2004. Rat models of skin wound healing: a review. Wound Repair Regen. 12:591-599. https://doi.org/10.1111/j.1067-1927.2004.12601.x
  7. Fang Y, Gong SJ, Xu YH, Hambly BD, Bao S. 2007. Impaired cutaneous wound healing in granulocyte/ macrophage colony-stimulating factor knockout mice. Br J Dermatol. 157:458-465. https://doi.org/10.1111/j.1365-2133.2007.07979.x
  8. Gasson JC. 1991. Molecular physiology of granulocytemacrophage colony-stimulating factor. Blood. 77: 1131-1145.
  9. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. 1999. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J. 13:1787-1795. https://doi.org/10.1096/fasebj.13.13.1787
  10. Hill AD, Naama HA, Calvano SE, Daly JM. 1995. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J Leukoc Biol. 58:634-642. https://doi.org/10.1002/jlb.58.6.634
  11. Jackson DM. 1953. The diagnosis of the depth of burning. Br J Surg. 40:588-596. https://doi.org/10.1002/bjs.18004016413
  12. Khodadadi L, Shafieyan S, Aghdami N, Baharvand H. 2008. Cell therapy in burn repair. Yakhteh Med J. 10:167-178.
  13. Kim HJ, Lee DH, Kim DK, Han GB, Kim HJ. 2008. The glycosylation and in vivo stability of human granulocytemacrophage colony-stimulating factor produced in rice cells. Biol Pharm Bull. 31:290-294. https://doi.org/10.1248/bpb.31.290
  14. Masucci G. 1996. New clinical applications of granulocytemacrophage colony-stimulating factor. Med Oncol. 13:149-154.
  15. Matsumotoa K, Nakamurab T. 1999. Hepatocyte growth factor and met: Molecular dialogue for tissue organization and repair. Animal Cell Syst (Former. Korean J Biol Sci), 2:1-8.
  16. Mery L, Girot R, Aractingi S. 2004. Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. Dermatology. 208:135-137. https://doi.org/10.1159/000076487
  17. Odland G, Ross R. 1968. Human wound repair. J Cell Biol. 39:135-168. https://doi.org/10.1083/jcb.39.1.135
  18. Yamamoto Y, Uede K, Yonei N, Furukawa F. 2007. Expression patterns of proliferating cell nuclear antigen in trichloroacetic acid peeled skin. J Dermatol. 34:95-98. https://doi.org/10.1111/j.1346-8138.2006.00225.x

Cited by

  1. Polydeoxyribonucleotide administration promotes the expression of proliferating cell nuclear antigen during liver regeneration in rats vol.19, pp.1, 2015, https://doi.org/10.1080/19768354.2014.997289